RT Journal Article
SR Electronic
T1 Cutaneous adverse effects of biologic medications
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 288
OP 299
DO 10.3949/ccjm.87a.19119
VO 87
IS 5
A1 Selena R. Pasadyn
A1 Daniel Knabel
A1 Anthony P. Fernandez
A1 Christine B. Warren
YR 2020
UL http://www.ccjm.org/content/87/5/288.abstract
AB Biologic therapies have become widely used but often cause cutaneous adverse effects. The authors discuss the cutaneous adverse effects of tumor necrosis factor (TNF) alpha inhibitors, epidermal growth factor receptor (EGFR) inhibitors, small-molecule tyrosine kinase inhibitors (TKIs), and cell surface-targeted monoclonal antibodies, including how to manage these reactions and when to refer to a dermatologist.